Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease. - Wikidata - wikimedia - TriplyDB

Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease.

Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease.

http://www.wikidata.org/entity/Q34630156

about

Gq/11-mediated signaling and hypertrophy in mice with cardiac-specific transgenic expression of regulator of G-protein signaling 2 Left Atrial Size and Function in a Canine Model of Chronic Atrial Fibrillation and Heart Failure Key roles of endothelin-1 and p38 MAPK in the regulation of atrial stretch response EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling Obesity and atrial fibrillation.Dietary ω3 fatty acids modulate the substrate for post-operative atrial fibrillation in a canine cardiac surgery model.A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block.Absence of the Regulator of G-protein Signaling, RGS4, Predisposes to Atrial Fibrillation and Is Associated with Abnormal Calcium Handling The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth.Deletion of Fn14 receptor protects from right heart fibrosis and dysfunction Seasonal Variation in Paroxysmal Atrial Fibrillation: A Systematic Review.Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation.Is Left Atrial Size a Predictor of Mortality after Coronary Artery Bypass Surgery? A Single Center Study.Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation.Alterations in atrial perfusion during atrial fibrillation.Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation.Molecular mechanisms of atrial fibrosis: implications for the clinic.Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis.Targeting cardiac fibrosis: a new frontier in antiarrhythmic therapy?Alteration of Endothelin 1, MCP-1 and Chromogranin A in patients with atrial fibrillation undergoing pulmonary vein isolation Predictors of conversion of recent-onset atrial fibrillation treated with vernakalant.Cardiac gene expression profiling - the quest for an atrium-specific biomarker.Oxidative stress, fibrosis, and early afterdepolarization-mediated cardiac arrhythmias.Neuroendocrine and haemodynamic changes in single-lead atrial pacing and dual-chamber pacing modes.Muscarinic type-1 receptors contribute to IK,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation.Refining the prognostic impact of functional mitral regurgitation in chronic heart failure.A comparison of the electrophysiologic and electroanatomic characteristics between the right and left atrium in persistent atrial fibrillation: Is the right atrium a window into the left?Calcium signalling silencing in atrial fibrillation.Endothelin-1 is associated with dilatation of the left atrium and can be an independent predictor of atrial fibrillation after mitral valve surgery.The significance of circulating endothelin-1 as a predictor of coronary artery disease status and clinical outcomes following coronary artery catheterization.EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure

P2860

Q21134156-2526B86A-F3D7-4F98-8BEC-D3AA464AD318 Q27330229-2F451AF8-6464-4608-AF24-5777FCE951ED Q28577467-06F9D3ED-D899-42FB-A233-67A31EDB46E6 Q30375302-6AF6C3BA-5338-4BC1-B95A-274D8834F81F Q30425918-511446B9-09AF-4A10-A2C5-FB59E2DFD3D8 Q33775560-931FBB7E-314A-46CE-81E0-3E7AB9EEE55F Q34359362-E25680C8-FD1C-4418-B748-315FD1C4A3EC Q35018362-0B627A72-BBF3-4A08-888B-40B769C71A02 Q35182874-73C72FEB-2D35-4F03-AEB5-FD9731326C44 Q35905389-BADCC583-5B64-4BBE-82A7-1496A4293AD4 Q36610320-294D53A7-8625-459A-A4A5-D80A42585509 Q36683886-0F742D34-C5F9-4692-BEBC-CDA1E55A8FCA Q37469012-0460B471-F028-447C-9B8E-4F740D6BF3EC Q37496071-AD14F809-CBC8-47B3-B20F-3E9FE2306B5F Q37719023-9D981A53-04D0-4F84-9E9A-8F5246F4CE66 Q38025390-EA797868-C60B-4DD9-BF49-C4DB5B72E7BD Q38234147-CFE33A13-AC07-4DBE-8447-6F84F422F080 Q38703115-F6E51641-7A04-437D-B3EA-E10E4F8DE9C4 Q38749008-78FFD833-53D2-448C-9925-0598E5B6A3C0 Q38819250-FD5C4FEC-B571-4D64-AA73-5CA0A56673EB Q39663271-3CCB4789-EDE2-4ECC-BD0C-5D11383E389B Q41493247-3CAC2393-35DC-4CE4-B1A2-AC48A2A0425D Q41732895-3182F378-98D2-4B21-93CB-DBBB025041D5 Q41875691-E2E997E5-294A-4E76-B109-69A73536E149 Q43246929-8C807FF4-6A4E-4A65-8FC6-55DCB96CD479 Q43867081-4B9CA9DF-5F23-44A5-9E0D-A78B3BF1E556 Q47228722-2360B380-75A8-4BA8-9CEF-E85BF9DE9291 Q47567410-8C74F66F-9AD7-41BE-B11F-E1078EC3B7EC Q48057363-E9D0EE82-7B91-4DD2-9927-D80F74D56ADD Q48089419-CD79D611-F01E-4CA8-B1AD-C30A1218ED9E Q50096721-82CA3EE1-7046-4479-BA28-08F99375E7B2 Q55026371-18BCA993-B320-4918-961C-80029106B008 Q55638585-70DA7AB9-0ADA-49FC-A727-DB0BA21DC3E0 Q58584159-320AE153-FE7F-4CAD-9AC5-0EEF788E31A4

P2860

Association of left atrial endothelin-1 with atrial rhythm, size, and fibrosis in patients with structural heart disease.

http://www.wikidata.org/entity/Q34630156

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Association of left atrial end ...... with structural heart disease.

@ast

Association of left atrial end ...... with structural heart disease.

@en

Association of left atrial end ...... with structural heart disease.

@nl

type

label

Association of left atrial end ...... with structural heart disease.

@ast

Association of left atrial end ...... with structural heart disease.

@en

Association of left atrial end ...... with structural heart disease.

@nl

prefLabel

Association of left atrial end ...... with structural heart disease.

@ast

Association of left atrial end ...... with structural heart disease.

@en

Association of left atrial end ...... with structural heart disease.

@nl

P1433

Q34630156-A6EA1A2A-AB45-48A4-9878-7F248987E25C

P1476

Q34630156-622692F2-361A-4290-BED2-71008F3DB952

P2093

Q34630156-0F02F30A-EAAD-46CA-8D05-E429556B3242

Q34630156-3BB78E38-E645-4F11-BC0C-EFFE065F37BB

Q34630156-4224B970-42C5-4125-AD40-280A5079E2AE

Q34630156-60AD1DAF-25F1-42DE-A611-FB08A6DD6009

Q34630156-620CE14E-1839-4E60-892D-2C097B82F1A1

Q34630156-C5DC0AA5-103A-4776-8B05-E10AC792F7F3

Q34630156-D42F6193-8A70-4A0C-885F-8F5955EB7AC6

P2860

Q34630156-0313CCB7-6CFC-418B-ABD5-F7B7179EDD62

Q34630156-0EBE8BEE-4D46-4761-85FF-8D2262852077

Q34630156-17D1DBCA-17CF-4305-AAF9-E0369F805D20

Q34630156-227625F7-74FC-4B57-96BE-154F795FF104

Q34630156-2985FE41-4705-4B05-8DCF-ADAE34A207DF

Q34630156-299F645A-C017-4531-A7ED-7FE168B0BC58

Q34630156-3DE00B3C-FF28-469E-BCE9-E3EC629F834E

Q34630156-41CF1698-4F8F-4650-AC49-8D9D0CA1CED9

Q34630156-4D53184D-02B3-43C5-9D86-C9DDA2BF7858

Q34630156-58D4FF39-55E9-46C2-91FA-D92B67697DC3

P304

Q34630156-91ED49EB-78AD-4D7E-98EA-540AF8B511F7

P31

Q34630156-A6248A8D-45C9-4E99-83CC-7622E024A4AB

P356

Q34630156-8E7CE9D5-E1AA-45E0-A14E-5952AF636906

P433

Q34630156-197A79EB-CD1C-41D4-9D94-076C2C0FF23C

P478

Q34630156-71E3B9D0-6E9E-44B9-97C9-8A91C3D8D553

P577

Q34630156-32D2138F-F6E6-4167-8C29-221099A1666E

P698

Q34630156-ADA07594-5706-4A70-8841-F6D36EDB16E2

P932

Q34630156-6E6A8A67-0E87-4940-B9FD-2249453A2E81

P356

CIRCEP.109.924985

P1433

Circulation: Arrhythmia and Electrophysiology

P1476

Association of left atrial end ...... with structural heart disease.

@en

P2093

A Marc Gillinov

http://www.w3.org/2001/XMLSchema#string

Andrew Zurick

http://www.w3.org/2001/XMLSchema#string

David R Van Wagoner

http://www.w3.org/2001/XMLSchema#string

Fadia Mayyas

http://www.w3.org/2001/XMLSchema#string

John Barnard

http://www.w3.org/2001/XMLSchema#string

Mark Niebauer

http://www.w3.org/2001/XMLSchema#string

Mina K Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP.

The human heart endothelin system: ET-1 synthesis, storage, release and effect.

N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study.

Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome.

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.

Plasma B-type natriuretic peptide levels predict postoperative atrial fibrillation in patients undergoing cardiac surgery.

Left atrial size: physiologic determinants and clinical applications.

Endothelin--role in vascular disease.

Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes.

The role of ANG II and endothelin-1 in exercise-induced diastolic dysfunction in heart failure.

P304

369-379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCEP.109.924985

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2010-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20495015

http://www.w3.org/2001/XMLSchema#string

P932

3050013

http://www.w3.org/2001/XMLSchema#string